Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of Rivaroxaban Assay for US Registration

NCT02333929 is registered in ClinicalTrials.gov with Diagnostica Stago as lead sponsor.

NCT NCT02333929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02333929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of Rivaroxaban Assay for US Registration
Lead sponsor
Diagnostica Stago
Phase
Observational
Overall status
Completed
Start date
March 31, 2015
Completion date
December 31, 2016
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients receiving rivaroxaban treatment